Where does NSE Products, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NSE Products, Inc. ranks #11,026 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NSE Products, Inc. hold?

NSE Products, Inc. holds 28 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is NSE Products, Inc.'s Innovation Score?

NSE Products, Inc. has an Innovation Score of 38.4 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NSE Products, Inc. focus on?

NSE Products, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 5 patents, ranking #681 of 1,943 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is NSE Products, Inc.'s patent grant rate increasing or decreasing?

NSE Products, Inc.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for NSE Products, Inc.'s patents?

NSE Products, Inc.'s patents average 12.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NSE Products, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NSE Products, Inc.

USPTO PatentsView assignee record - 28 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, NSE ranks #11,026 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 18 technology areas.

#11,026
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.4/100): 12.2
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11026 · US Corporation #11,026 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #11,026/49,997
PHOTO-FINISH Nagase ChemteX
CPC-FOCUS A61N · 18 areas
INNOV-THIN 38.4/100
CLAIMS-RICH 12.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nagase ChemteX Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How NSE’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (30%) Velocity 4.4 pts (11%) Breadth 15.0 pts (39%) Claim depth 7.3 pts (19%)

Qualcomm Incorporated · highest

85
Chips & Media · near

38
NSE Products · this assignee

38
Optex · near

38
Sakata Seed · near

38
Vivex Biologics Group · near

38
3D Lighting… · lowest

7

What this shows NSE's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for NSE?

Each dot is one of NSE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). NSE’s own 12.2 claims/patent is ABOVE the 10.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

NSE vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where NSE's grants concentrate

NSE Products, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 17.9% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2018 (7 grants) versus a trough of 1 in 2019. By volume, NSE sits between NEW World Medical, Inc. and NeoChord, Inc..

NSE's three-year grant acceleration

NSE Products, Inc. shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

NEW World Medical

28
Nexter Munitions

28
Nippon Filcon

28
Nissin Chemical I…

28
Nutramax Laborato…

28
Nagase Chemtex

28
Nemoto Kyorindo

28
Neochord

28
NSE Products ◀

28

What this shows NSE holds 28 patents at rank #11,019, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NSE

By rank, the assignees closest to #11,019 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in NSE's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for NSE, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), NSE ranks #681 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Vivex Biologics Group, Inc. 38 Chips & Media, Inc 38 Optex Co., Ltd. 38 Sakata Seed Corporation 38

NSE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

NSE Products, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	21.4%
2017	4	14.3%
2018	7	25.0%
2019	1	3.6%
2020	4	14.3%
2021	1	3.6%
2022	2	7.1%
2024	2	7.1%
2025partial year	1	3.6%

Which technologies does NSE Products, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 4

A46B - Brushes 4

A47K - Sanitary Equipment NOT Otherwise Provided FOR ; Toilet Accessories 4

A46D - Manufacture OF Brushes 3

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 3

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A61B - DIAGNOSIS; SURGERY; Identification 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

A45D - Hairdressing OR Shaving Equipment ; Equipment FOR Cosmetics OR Cosmetic Treatments, e.g. FOR Manicuring OR Pedicuring 1

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NSE Products, Inc.'s patent record in context - here's where to go next.

NSE Products, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 17.9% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #11,026 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NSE Products, Inc. against NEW World Medical, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.